Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels

Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels

US Patent 10829532 · Granted Nov 10, 2020

Estimated economic value: $27,886,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of using ALK2 inhibitors2025
Method for producing levulinic acid2025
Methods of treating iron overload with a BMP inhibitor2025
Methods of using activin receptor type IIB variants2025
Cache circuit that selectively stores data blocks to dynamically optimize for re2025
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereo2025
GDNF fusion polypeptides and methods of use thereof2025
Methods for treating heterotopic ossification2025
Activin receptor type IIA variants and methods of use thereof2025
ALK7 binding proteins and uses thereof2025
Activin receptor type IIa variants and methods of use thereof2025
Compositions and methods for treating pulmonary hypertension2025